• Flanders Investment & Trade
  • Team Vesalius

Eric Van Cutsem is full professor and Division Head of Digestive Oncology at University of Leuven (KUL) and University Hospitals Gasthuisberg, Leuven, Belgium.

Eric Van Cutsem

University Hospital Leuven

Head of Digestive Oncology

He is Member of the Belgian Royal Academy of Medicine and president of the Belgian Foundation against Cancer. He received several awards, amongst which were in 2019 the ESMO Award and the European Awards in Medicine for Cancer Research.

His research focuses on the development of new treatment strategies for GI cancers, incl. drug development and identification of molecular markers and diagnostic tools. In 2013, Capital magazine ranked him in the top 3 reputed colon cancer experts globally. Thomson Reuters ranks him in the top 1% for impact in his domain. Van Cutsem is also a member of several scientific organizations at home and abroad.

Team Vesalius visionairies

Flanders’ life sciences industry: the perfect combo of biotech, medtech, pharma and healthcare

Defining Flanders’ life sciences industry as diverse is an understatement. From young start-ups to established local firms and multinationals: the entire value chain – from research and discovery to development and commercialization – is represented in Belgium’s northern region. Thanks to fertile cross-pollination between biotech, medtech, pharmaceuticals and healthcare, Flanders offers a unique life sciences ecosystem that is underpinned by a robust financing landscape and a supportive government. Will your company claim its place in this dynamic hub?